Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,399 public trials 1,305 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study

NCT02195518

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Changchun, Jilin, China
  • GSK Investigational Site Chengdu, Sichuan, China
View Trial Details
Completed

Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B

NCT01943799

Conditions
Blood-Borne Infections, Chronic HBV Infection, Communicable Diseases, +9 more
Locations
  • Dumont-UCLA Liver Transplant Center Los Angeles, California, United States
  • Huntington Medical Research Institutes Pasadena, California, United States
  • Kaiser Permanente Sacramento, California, United States
  • Kaiser Permanente San Diego, California, United States
View all 17 locations
View Trial Details
Completed

Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)

NCT01097044

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • Mt. Sinai New York, United States
  • Carolina's Medical Center Cannon Research Charlotte, North Carolina, United States
View Trial Details
Completed

Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis

NCT01904409

Conditions
Digestive System Diseases, Fibrosis, Liver Cirrhosis, +3 more
Locations
  • Salix Investigative Site Birmingham, Alabama, United States
  • Salix Investigative Site Dothan, Alabama, United States
  • Salix Investigative Site Mobile, Alabama, United States
  • Salix Investigative Site Tucson, Arizona, United States
View all 120 locations
View Trial Details
Completed

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

NCT03002818

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus (HCV), +15 more
Locations
  • Kantonsspital St. Gallen Sankt Gallen, Canton of St. Gallen, Switzerland
  • Inselspital, Universitaetsklin Bern, Switzerland
  • Fondazione Epatocentro Ticino Lugano, Switzerland
  • Hopital Neuchatelois Neuchâtel, Switzerland
View Trial Details

Related conditions